In CVM stock forecast 2025 scenarios, bullish cases project 25% gains over current levels if key phase trials deliver favorable outcomes. The risk profile remains tied to regulatory review windows that can cause price swings. Thank you so much. Good morning everyone. Thank you for the opportunity. My first question is related to your mix, your sales mix. TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions. For CVM stock forecast 2025, consensus models from market research firms point to a median target of $9.75, supported by positive clinical data pipelines. Volume spikes in recent sessions hint at accumulation by larger funds, often preceding bullish runs in small-cap biotech names.
